BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 2574015)

  • 1. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
    Swen J; Rashkovsky OM; Ket JM; Koot HW; Hermans J; Agoston S
    Anesth Analg; 1989 Dec; 69(6):752-5. PubMed ID: 2574015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria for use of pancuronium bromide, vecuronium bromide, atracurium besylate, tubocurarine chloride, metocurine iodide, pipecuronium bromide, and doxacurium chloride in adults.
    Donnelly AJ; Golembiewski JA; Skupski R; Wojtynek JE
    Clin Pharm; 1992 May; 11(5):435-41. PubMed ID: 1349856
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of pipecuronium bromide during halothane or enflurane anesthesia--a comparison with pancuronium regarding the optimal dose and the effect of volatile anesthetics on neuromuscular blockade].
    Amaki Y; Yamamura H
    Masui; 1993 Jun; 42(6):876-82. PubMed ID: 8391589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
    Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
    Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative pharmacokinetics of pipecuronium bromide, pancuronium bromide and vecuronium bromide in anesthetized man].
    Yajima C; Sugai N; Hanaoka K; Numata K; Yamamoto K; Kushida Y; Murakami S; Yamamura H
    Masui; 1990 Jul; 39(7):882-9. PubMed ID: 1976829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relaxation: current controversy.
    Savarese JJ
    Can Anaesth Soc J; 1986 May; 33(3 Pt 2):S1-4. PubMed ID: 2872951
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuromuscular effects of pipecuronium bromide.
    Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS
    Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arduan muscle relaxation prolonged with norcuron.
    Fister T
    Ther Hung; 1991; 39(3):125-7. PubMed ID: 1687841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of different doses of pipecuronium bromide during nitrous-oxide-fentanyl anaesthesia in adult surgical patients.
    Sanfilippo M; Fierro G; Vilardi V; Rosa G; De Gregorio AL; Gasparetto A
    Eur J Anaesthesiol; 1992 Jan; 9(1):49-53. PubMed ID: 1310464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl.
    Wierda JM; Richardson FJ; Agoston S
    Anesth Analg; 1989 Mar; 68(3):208-13. PubMed ID: 2537588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of vecuronium, atracurium and pancuronium in divided doses: effect on onset and duration of action.
    Brady MM; Mirakhur RK; Clarke RS
    Eur J Anaesthesiol; 1988 Jul; 5(4):243-9. PubMed ID: 2904367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular and cardiovascular effects of pipecuronium.
    Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL
    Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular effects of atracurium during halothane-nitrous oxide and enflurane-nitrous oxide anesthesia in humans.
    Rupp SM; McChristian JW; Miller RD
    Anesthesiology; 1985 Jul; 63(1):16-9. PubMed ID: 3160265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vecuronium-induced neuromuscular blockade during enflurane, isoflurane, and halothane anesthesia in humans.
    Rupp SM; Miller RD; Gencarelli PJ
    Anesthesiology; 1984 Feb; 60(2):102-5. PubMed ID: 6141748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
    Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of atracurium, pipecuronium, and vecuronium for tracheal intubation.
    Cozanitis DA; Hofmockel R; Benad G; Sitarek U
    Acta Anaesthesiol Belg; 1987; 38(1):77-81. PubMed ID: 2884796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pipecuronium-induced neuromuscular blockade during nitrous oxide-fentanyl, enflurane, isoflurane, and halothane anesthesia in surgical patients.
    Naguib M; Seraj M; Abdulrazik E
    Anesth Analg; 1992 Aug; 75(2):193-7. PubMed ID: 1321569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.